NCT05467462View on ClinicalTrials.gov

Efficacy of Four Different Treatment Regimes on Postpartum Hemorrhage

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

January 25, 2023

Study Completion Date

January 25, 2023

Conditions
Postpartum Hemorrhage
Interventions
DRUG

I.V carbetocin administration

Group I: carbetocin was intravenously administered immediately after birth of the baby.

DRUG

I.V Oxytocin administration

Group II: Oxytocin the oxytocin infusion consisting of 20 IU dissolved in 500 mL of normal 0.9 % sodium chloride solution and infused at a rate of 125 mL/h was administered immediately after clamping the umbilical cord.

DRUG

I.V carbetocin and tranexamic acid administration

Group III: carbetocin and tranexamic acid 100-mg carbetocin was intravenously administered immediately after birth of the baby and tranexamic acid infusion consisting of 1gr dissolved in 100 mL of normal 0.9 % sodium chloride solution was administered immediately after clamping the umbilical cord.

DRUG

I.V Oxytocin and tranexamic acid administration

Group IV: oxytocin and tranexamic acid the oxytocin infusion consisting of 20 IU dissolved in 500 mL of normal 0.9 % sodium chloride solution and infused at a rate of 125 mL/h was administered and tranexamic acid infusion consisting of 1gr dissolved in 100 mL of normal 0.9 % sodium chloride solution was administered immediately after clamping the umbilical cord

Trial Locations (1)

Unknown

Bezmialem Vakif University, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER